Building on a Long Legacy of Medical Breakthroughs
At Tanabe Pharma America, we take on seemingly insurmountable obstacles – knowing it has the power to make a real difference in the lives of people struggling with debilitating diseases. It’s our responsibility and our honor.
OUR HISTORY
Our company has altered the course of history with the mantra that scientific breakthroughs can transform lives.
For more than 300 years, our parent company, Tanabe Pharma Corporation (previously Mitsubishi Tanabe Pharma Corporation) in Japan, has proudly pursued medical advances; we’ve discovered and produced several first in class medicines for serious diseases, including multiple sclerosis (MS) and diabetes mellitus (DM).
While our global successes represent a strong part of our identity, we continue to build on this legacy by seeking new therapies for the pressing needs of patients in the U.S. We pledge to uphold our legacy and wayfaring spirit – always seeking out solutions to their most pressing needs.
Company Snapshot
+300
Years of innovation
Headquartered in Jersey City, NJ
Not many companies have a legacy as long as ours. For over 300 years, we have maintained the highest ethical standards and have placed top priority on fairness and integrity, all while contributing to the healthier lives of people around the world through the creation of pharmaceuticals.
Each one of us is innovative and shares a heartfelt responsibility to provide medicines that make life better for all. Innovation begins with you.
OUR PEOPLE
Who We Are
Our people are tenacious and thrive on solving complex problems in science and medicine. This drive and personal commitment is at the core of our strength as an organization.
Meet Our PresidentOur logo takes the form of hands gently enfolding the health of people around the world, symbolizing Tanabe Pharma’s future growth and unlimited potential as a global research-driven pharmaceutical company.
These values clearly outline the expected behaviors and actions that are observable in our day-to-day work. They provide a practical guide on how we interact, collaborate, and perform our duties.
We don’t wait for someone else to show us the way. We are passionate, proactive, and resourceful, which gets us started and keeps us moving forward.
We use our imagination, talent, and intelligence to develop bold ideas and reach our goals. We are not focused on what has been done, but on what we are able to do.
We are motivated to make a difference, to move quickly and courageously toward our goals. Our determination is our strength.
We see our projects to completion. The path is not always smooth, and mistakes are sometimes made, but we overcome challenges and achieve our objectives.
These represent the attitudes and perspectives we cultivate. They shape how we think, approach challenges, and interact with others.
We understand that when working together, we are capable of so much more. Our individual abilities are strengthened by embracing the perspectives of others.
We put the patient first, and that motivates us to do our best. We are truly fortunate to be in a position to help others.
When you join TPA, you’ll join a team dedicated to making a real difference in people’s lives.
Registration of Clinical Trial Information and Disclosure of Results
a. Registration of our clinical trial information, and disclosure of results, to clinical trial registries
TPA will register and disclose information on publicly accessible clinical trial registries such as ClinicalTrials.gov regarding clinical trials that are being conducted or have been conducted.
b. Disclosure of clinical trial summary results
TPA will disclose the results from clinical trials in patients that form part of the submission package for products approved in the United States. Results will not be disclosed if TPA decides that disclosure may lead to identification of clinical trial participants. Results may not be disclosed under any of the following conditions:
- A third party, such as a company involved in joint development, has not agreed to disclosure.
- Disclosure may interfere with publication in medical journals.
- Disclosure may interfere with the protection of intellectual property rights.